Shields PG - Search Results

1

Interacting effects of the serotonin transporter gene and neuroticism in smoking practices and nicotine dependence.

Lerman C, Caporaso NE, Audrain J, Main D, Boyd NR, Shields PG. Lerman C, et al. Among authors: shields pg. Mol Psychiatry. 2000 Mar;5(2):189-92. doi: 10.1038/sj.mp.4000672. Mol Psychiatry. 2000. PMID: 10822347

2

Depression and self-medication with nicotine: the modifying influence of the dopamine D4 receptor gene.

Lerman C, Caporaso N, Main D, Audrain J, Boyd NR, Bowman ED, Shields PG. Lerman C, et al. Among authors: shields pg. Health Psychol. 1998 Jan;17(1):56-62. doi: 10.1037//0278-6133.17.1.56. Health Psychol. 1998. PMID: 9459071

3

The role of the serotonin transporter gene in cigarette smoking.

Lerman C, Shields PG, Audrain J, Main D, Cobb B, Boyd NR, Caporaso N. Lerman C, et al. Among authors: shields pg. Cancer Epidemiol Biomarkers Prev. 1998 Mar;7(3):253-5. Cancer Epidemiol Biomarkers Prev. 1998. PMID: 9521442

4

Evidence suggesting the role of specific genetic factors in cigarette smoking.

Lerman C, Caporaso NE, Audrain J, Main D, Bowman ED, Lockshin B, Boyd NR, Shields PG. Lerman C, et al. Among authors: shields pg. Health Psychol. 1999 Jan;18(1):14-20. doi: 10.1037//0278-6133.18.1.14. Health Psychol. 1999. PMID: 9925041

5

Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial.

Lerman C, Shields PG, Wileyto EP, Audrain J, Hawk LH Jr, Pinto A, Kucharski S, Krishnan S, Niaura R, Epstein LH. Lerman C, et al. Among authors: shields pg. Health Psychol. 2003 Sep;22(5):541-8. doi: 10.1037/0278-6133.22.5.541. Health Psychol. 2003. PMID: 14570538 Clinical Trial.

6

Interacting effects of genetic predisposition and depression on adolescent smoking progression.

Audrain-McGovern J, Lerman C, Wileyto EP, Rodriguez D, Shields PG. Audrain-McGovern J, et al. Among authors: shields pg. Am J Psychiatry. 2004 Jul;161(7):1224-30. doi: 10.1176/appi.ajp.161.7.1224. Am J Psychiatry. 2004. PMID: 15229055

7

Nicotine metabolism and CYP2D6 phenotype in smokers.

Caporaso NE, Lerman C, Audrain J, Boyd NR, Main D, Issaq HJ, Utermahlan B, Falk RT, Shields P. Caporaso NE, et al. Cancer Epidemiol Biomarkers Prev. 2001 Mar;10(3):261-3. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11303596 Clinical Trial.

8

Lack of association of tyrosine hydroxylase genetic polymorphism with cigarette smoking.

Lerman C, Shields PG, Main D, Audrain J, Roth J, Boyd NR, Caporaso NE. Lerman C, et al. Among authors: shields pg. Pharmacogenetics. 1997 Dec;7(6):521-4. doi: 10.1097/00008571-199712000-00012. Pharmacogenetics. 1997. PMID: 9429239 No abstract available.

9

Tryptophan hydroxylase gene variant and smoking behavior.

Lerman C, Caporaso NE, Bush A, Zheng YL, Audrain J, Main D, Shields PG. Lerman C, et al. Among authors: shields pg. Am J Med Genet. 2001 Aug 8;105(6):518-20. doi: 10.1002/ajmg.1476. Am J Med Genet. 2001. PMID: 11496367

10

Dopamine D4 receptors and the risk of cigarette smoking in African-Americans and Caucasians.

Shields PG, Lerman C, Audrain J, Bowman ED, Main D, Boyd NR, Caporaso NE. Shields PG, et al. Cancer Epidemiol Biomarkers Prev. 1998 Jun;7(6):453-8. Cancer Epidemiol Biomarkers Prev. 1998. PMID: 9641486

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

321 results

Search Page